Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Merck Helps Accelerate Global Access to Affordable Vaccines

Merck Helps Accelerate Global Access to Affordable Vaccines

27th April 2018

Merck has announced a partnership with Oxford University’s Jenner Institute. Together they plan to develop a vaccine manufacturing facility in Ghana with improved manufacturing processes for adenovirus vaccines using Merck products, systems and technologies on a real-world feed stream. This will allow the partnership to improve global heath by developing a cost-effective and transferable manufacturing process that can be practiced in a cleanroom to minimize contamination (in line with the high biological safety requirements for viral vectors), and used to accelerate vaccine development and manufacturing worldwide, thus making vaccines more affordable and available.

“The collaboration with the Jenner Institute will facilitate access to affordable vaccines while improving the global response to disease outbreaks,” said Udit Batra, Member of the Merck Executive Board and CEO, Life Science. “Merck is committed to expanding access to advanced drug therapies, especially in low- and middle-income countries. Together with our partners we have shaped how vaccine production is done today and are helping to solve the toughest problems of tomorrow.”

“Merck is an excellent partner for enhancing our capabilities in adenovirus vaccine development, as the newly developed process should match or exceed our existing process in terms of productivity and purity. Such improvements should help advance the development of clinical-grade, injectable drug product for use in clinical trials and other research applications” said Adrian Hill, Director of the Jenner Institute at Oxford University.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.